论文部分内容阅读
目的回顾性分析采用微创技术治疗移植肾发生的原发性肾细胞癌的中期疗效。材料与方法此回顾性研究经每个参与机构的学术评审委员会批准,免除病人的知情同意。本研究遵循HIPAA要求。本研究组病人的纳入条件符合欧洲泌尿生殖放射学网络制定的标准,对移植肾受者进行了
Objective To retrospectively analyze the medium-term efficacy of minimally invasive surgery in the treatment of primary renal cell carcinoma of renal allograft. Materials and Methods This retrospective study was approved by the Academic Review Board of each of the participating institutions and the patient’s informed consent was waived. This study follows HIPAA requirements. The study group patients with inclusion criteria in line with the European Genitourinary Radiology Network standards developed for renal transplant recipients